Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) EBT Margin (2020 - 2025)

BioAtla (BCAB) has disclosed EBT Margin for 4 consecutive years, with 459.1% as the latest value for Q4 2025.

  • For Q4 2025, EBT Margin changed N/A year-over-year to 459.1%; the TTM value through Dec 2025 reached 2923.3%, down 228172.0%, while the annual FY2025 figure was 2923.1%, 228152.0% down from the prior year.
  • EBT Margin hit 459.1% in Q4 2025 for BioAtla, down from 96.16% in the prior quarter.
  • Across five years, EBT Margin topped out at 96.16% in Q3 2024 and bottomed at 12152.4% in Q2 2021.
  • Average EBT Margin over 3 years is 4235.89%, with a median of 459.1% recorded in 2025.
  • On a YoY basis, EBT Margin climbed as much as -937714bps in 2021 and fell as far as -937714bps in 2021.
  • BioAtla's EBT Margin stood at 12152.4% in 2021, then soared by 99bps to 96.16% in 2024, then crashed by -377bps to 459.1% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 459.1%, 96.16%, and 12152.4% for Q4 2025, Q3 2024, and Q2 2021 respectively.